Francesco Rodeghiero Selected Research

Type 1 von Willebrand Disease

3/2013	VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
4/2011	Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
11/2010	The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
4/2009	Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study.
5/2008	Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
4/2008	Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach.
4/2008	Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
1/2007	Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Rodeghiero Research Topics

Disease

44	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 10/2006
39	Hemorrhage 01/2021 - 01/2003
17	Thrombosis (Thrombus) 01/2019 - 09/2002
10	Neoplasms (Cancer) 11/2013 - 11/2002
9	Essential Thrombocythemia 01/2022 - 09/2002
9	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2015 - 04/2012
8	Thrombocytopenia (Thrombopenia) 01/2022 - 04/2008
8	von Willebrand Diseases (von Willebrand's Disease) 06/2014 - 01/2002
8	Type 1 von Willebrand Disease 03/2013 - 01/2007
6	Infections 01/2018 - 02/2008
5	Polycythemia Vera 01/2019 - 09/2002
5	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 05/2016 - 10/2009
5	Venous Thromboembolism 03/2012 - 09/2002
4	Multiple Myeloma 06/2006 - 11/2002
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 08/2002
3	Thrombocytosis (Thrombocythemia) 08/2015 - 09/2003
3	Hemolysis 11/2014 - 04/2009
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2013 - 03/2002
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2013 - 01/2012
3	Thrombophilia 03/2012 - 08/2002
3	Polycythemia (Erythrocytosis) 01/2012 - 09/2003
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2019 - 12/2009
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 09/2017
2	Liver Diseases (Liver Disease) 09/2017 - 01/2015
2	Evans Syndrome 05/2016 - 10/2009
2	Disease Progression 07/2015 - 01/2015
2	Cytopenia 11/2014 - 10/2009
2	Hematologic Neoplasms (Hematological Malignancy) 07/2014 - 03/2002
2	Inherited Blood Coagulation Disorders 09/2013 - 12/2008
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2013 - 05/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2013 - 11/2012
2	Lymphoma (Lymphomas) 11/2012 - 01/2012
2	Hemolytic Anemia 07/2012 - 04/2009
2	Vascular System Injuries 02/2011 - 01/2003
2	Leukemia 10/2010 - 05/2006
2	Thromboembolism 03/2009 - 11/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2005 - 05/2004
1	Chronic Disease (Chronic Diseases) 06/2022
1	Fatigue 06/2022
1	COVID-19 01/2021
1	Neonatal Alloimmune Thrombocytopenia 01/2020
1	Hepatitis C 01/2019
1	Acute Promyelocytic Leukemia 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Body Weight (Weight, Body) 09/2018
1	Headache (Headaches) 09/2018
1	Fever (Fevers) 09/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2017
1	Pulmonary Hypertension 01/2017

Drug/Important Bio-Agent (IBA)

39	Inosine Triphosphate (ITP)IBA 01/2022 - 10/2006
14	von Willebrand FactorIBA 06/2014 - 01/2002
12	Thrombopoietin ReceptorsIBA 01/2022 - 11/2013
8	romiplostim FDA Link 12/2020 - 11/2010
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 10/2010
6	Biological ProductsIBA 11/2013 - 04/2008
6	Factor VIII (Coagulation Factor VIII)IBA 01/2013 - 08/2004
5	Pharmaceutical PreparationsIBA 09/2018 - 04/2008
5	Bendamustine Hydrochloride FDA Link 11/2013 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 03/2013 - 01/2007
4	eltrombopag FDA Link 01/2021 - 01/2015
4	AnticoagulantsIBA 01/2019 - 09/2002
4	Rituximab (Mabthera)FDA Link 01/2018 - 04/2013
4	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 06/2014 - 01/2005
4	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2013 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 07/2012 - 01/2003
4	Hydroxyurea (Hydrea)FDA LinkGeneric 05/2012 - 05/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 02/2007
3	Thrombopoietin (c-mpl Ligand)IBA 09/2017 - 11/2010
3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2014 - 11/2002
3	AntigensIBA 01/2013 - 01/2009
3	Angiogenesis InhibitorsIBA 04/2012 - 11/2008
3	factor V LeidenIBA 03/2012 - 09/2002
3	Erythropoietin FDA Link 01/2012 - 09/2004
3	Thalidomide (Thalomid)FDA Link 03/2009 - 01/2003
3	Protein CIBA 08/2004 - 08/2002
3	Factor V (Coagulation Factor V)IBA 08/2004 - 09/2002
2	Reticulin (Reticular Fiber)IBA 01/2019 - 11/2013
2	InterferonsIBA 01/2019 - 07/2014
2	SteroidsIBA 10/2015 - 06/2013
2	Lenalidomide (CC 5013)FDA Link 08/2015 - 03/2009
2	Immunoglobulins (Immunoglobulin)IBA 05/2014 - 04/2013
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 09/2013 - 12/2008
2	AntibodiesIBA 06/2013 - 02/2008
2	asialo-von Willebrand FactorIBA 01/2013 - 08/2009
2	Sunitinib (Sutent)FDA Link 04/2012 - 03/2009
2	Sorafenib (BAY 43-9006)FDA Link 04/2012 - 03/2009
2	Bevacizumab (Avastin)FDA Link 04/2012 - 03/2009
2	Prothrombin (Factor II)IBA 03/2012 - 08/2004
2	Oxygen (Dioxygen)IBA 01/2012 - 05/2011
2	Fibrinogen (Factor I)FDA Link 02/2011 - 07/2009
1	ThromboxanesIBA 01/2022
1	CollagenIBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2019
1	CreatinineIBA 09/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2018
1	Thromboxane B2IBA 01/2018

Therapy/Procedure

16	Therapeutics 06/2022 - 02/2004
10	Splenectomy 01/2021 - 02/2008
5	Drug Therapy (Chemotherapy) 01/2022 - 03/2009
1	Self Administration (Administration, Self) 01/2020